Recombinant ADAMTS13
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant ADAMTS13, covering 2025-10-07 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program